California court hangs out a welcome sign: Drug makers can be sued here
(By Ed Silverman for STAT) In a closely watched decision, the California Supreme Court ruled 4-3 Monday that hundreds of
Read More
Part D/Prescription Drugs
Another Biosimilar Wins FDA Approval
U.S. Food and Drug Administration (FDA) approved Novartis’s Sandoz drug Erelzi (biosimilar copy of Amgen’s Enbrel) on Tuesday but it
Read MoreMaker Of EpiPen To Sell Generic Version For Half The Price
(By Alison Kodjak for NPR) Treatment for life-threatening allergic reactions is about to get a little cheaper. Mylan, the maker
Read More‘America’s Other Drug Problem’: Copious Prescriptions For Hospitalized Elderly
(By Anna Gorman for Kaiser Health News) SANTA MONICA, Calif. — Dominick Bailey sat at his computer, scrutinizing the medication lists
Read MoreBehind the stealth ad campaigns for the EpiPen and other drugs
(By Rebecca Robbins for STAT) Mylan Pharmaceuticals has spent millions this year on television ads and celebrity testimonials that implicitly promote the EpiPen — without
Read MoreIn Boston’s ‘Safe Space,’ Surprising Insights Into Drug Highs
(By Martha Bebinger, WBUR for Kaiser Health News) Some arrive on their own, worried about what was really in that
Read MoreSenators want to know what FDA is doing to make EpiPen rivals available
(By Ed Silverman for STAT) While anger is directed at Mylan Pharmaceuticals over the rising cost of its EpiPen device,
Read MoreTaking a look at one attempt to rein in the EpiPen cost problem
As the finger-pointing and public outrage rages on over EpiPen pricing, Mylan recently announced plans to offer discounts, via coupon,
Read MoreIllegally Made Fentanyl Seems To Be Fueling A Spike In Overdoses
(By Katherine Hobson for NPR) Federal data suggest illegally manufactured fentanyl, a drug that is 50 to 100 times stronger
Read MoreReport For State Insurance Commissioners Offers Options To Improve Drug Access
(By Michelle Andrews for Kaiser Health News) As prescription drug costs continue to rise, ensuring that consumers have access to
Read More